English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduPatients with a dysfunctional aortic heart valve who received a new, prosthetic valve through a minimally invasive procedure had similar outcomes at five years as those who underwent open-heart surgery, a new study shows.
Tag: Cardiovascular Innovation and Intervention
Redo Transcatheter Aortic Valve Replacement Proven Effective, Safe
Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. They now show that redo TAVR procedures are both safe and effective when compared with situations in which patients with similar risk profiles undergo the same procedure for the first time.
Study: Transcatheter Mitral Valve Repair Safe, Successful
Long-awaited outcomes data of transcatheter edge-to-edge procedures to repair patients’ leaky mitral valves revealed the minimally invasive procedure to be safe and effective in nearly 90% of patients, according to Cedars-Sinai physician-scientists.
ACC Scientific Session 2023 to Feature Smidt Heart Institute Experts
Experts from the Smidt Heart Institute at Cedars-Sinai, California’s premier cardiology and heart surgery provider, will present innovative research findings and lead discussions on the latest high-impact medical breakthroughs during the American College of Cardiology (ACC) Annual Scientific Session & Expo March 4-6 in New Orleans.
Smidt Heart Institute at 5: Breakthroughs in Research, Patient Care
Marking the five-year anniversary of the $50 million gift that named the Smidt Heart Institute, Cedars Sinai is highlighting major research breakthroughs and clinical innovations pioneered by one of the nation’s leading destinations for cardiac care.